Insulin production by the B-cell consists of a series of post- translational events: introduction of preproinsulin into the lumen of the RER; prepro- to proinsulin conversion; transport of proinsulin to the Golgi complex and packaging into immature, clathrin coated granules; proinsulin to insulin conversion. granule acidification and clathrin uncoating; granule release, storage or degradation. The ultimate aim of this Project is to characterize each step in molecular detail. Only then will it be possible to define the lesions responsible for defective insulin production in diabetes. The experiments depend upon native islets (rat or calf) or rat insulinoma cells. The methods combine analytical biochemistry, cell biology, morphology and recombinant DNA techniques.
The specific aims and experimental approaches are: 1. Introduction of preproinsulin into the RER: The signal (leader) sequence carries structural information responsible for penetration through the RER membrane. This region of the insulin gene will be mutated (site directed mutagenesis of rat insulin II gene) and the mutated gene transfected into AtT20 cells (pituitary cell line). Production of insulin and its precursors will be compared with AtT20 cells transfected with the native gene. Relative rates of synthesis, conversion and intracellular transport/targeting/packaging will be examined. 2. Targeting/packaging of proinsulin into granules, and subsequent conversion to insulin: A similar approach will be used to study the tertiary and quarternary structural information on the proinsulin molecule responsible for recognition in the Golgi complex and by the converting enzyme(s). 3. Granule maturation (clathrin uncoating), intragranular acidification and proinsulin conversion: Isolated, intact granules will be used. The mechanism responsible for removal of clathrin from immature granules will be studied. The experiments will also address the issue of whether uncoating, acidification and conversion are merely contemporaneous or actually interdependent events. 4. The preperential release of newly synthesized insulin: The mechanism underlying preferential release of new insulin will be studied using native rat islets. The hypothesis that intimate association of newly formed granules with the cytoskeleton is responsible will be evaluated by examining the effect of agents known to disturb microtubule polymerization. 5. Intracellular degradation of granule contents: After fusion of granules with lysosomes (crinophagy) insulin is predicted to be degraded less rapidly than C-peptide/proinsulin (since it is stabilized in the crystal form). The rates of insulin and C-peptide degradation will be measured in rat islet B-cells. How granules and lysosomes come in contact and fuse is unknown. The hypothesis that the cytoskeleton serves as the framework for crinophagy will be tested experimentally.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK035292-06
Application #
3233574
Study Section
Metabolism Study Section (MET)
Project Start
1985-04-01
Project End
1991-06-30
Budget Start
1990-07-01
Budget End
1991-06-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Geneva
Department
Type
DUNS #
481076537
City
Geneva
State
Country
Switzerland
Zip Code
CH-12-11
Dotta, F; Previti, M; Neerman-Arbez, M et al. (1998) The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific. Endocrinology 139:316-9
Sadoul, K; Lang, J; Montecucco, C et al. (1995) SNAP-25 is expressed in islets of Langerhans and is involved in insulin release. J Cell Biol 128:1019-28
Vollenweider, F; Kaufmann, J; Irminger, J C et al. (1995) Processing of proinsulin by furin, PC2, and PC3 in (co) transfected COS (monkey kidney) cells. Diabetes 44:1075-80
Halban, P A (1994) Proinsulin processing in the regulated and the constitutive secretory pathway. Diabetologia 37 Suppl 2:S65-72
Ferber, S; Schnedl, W J; BeltrandelRio, H et al. (1994) Molecular strategies for the treatment of diabetes. Transplant Proc 26:363-5
Irminger, J C; Vollenweider, F M; Neerman-Arbez, M et al. (1994) Human proinsulin conversion in the regulated and the constitutive pathways of transfected AtT20 cells. J Biol Chem 269:1756-62
Halban, P A; Irminger, J C (1994) Sorting and processing of secretory proteins. Biochem J 299 ( Pt 1):1-18
Neerman-Arbez, M; Cirulli, V; Halban, P A (1994) Levels of the conversion endoproteases PC1 (PC3) and PC2 distinguish between insulin-producing pancreatic islet beta cells and non-beta cells. Biochem J 300 ( Pt 1):57-61
Orci, L; Halban, P; Perrelet, A et al. (1994) pH-independent and -dependent cleavage of proinsulin in the same secretory vesicle. J Cell Biol 126:1149-56
Vollenweider, F; Irminger, J C; Halban, P A (1993) Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells. Diabetologia 36:1322-5

Showing the most recent 10 out of 34 publications